Cytokinetics Inc. buy Truist Financial Co.
Start price
28.12.23
/
50%
€76.00
Target price
28.12.24
€77.64
Performance (%)
-19.08%
Price
26.04.24
€61.50
Summary
This prediction is currently active. The prediction for Cytokinetics Inc. disappoints with a performance of -19.08%. This prediction currently runs until 28.12.24. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Cytokinetics Inc. | -3.150% | -3.150% |
| iShares Core DAX® | 2.594% | -1.861% |
| iShares Nasdaq 100 | 3.553% | -2.064% |
| iShares Nikkei 225® | 0.687% | -8.704% |
| iShares S&P 500 | 2.209% | -1.988% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Discuss Cytokinetics Inc.
Cytokinetics, Incorporated (NASDAQ: CYTK) had its price target raised by analysts at Truist Financial Co. from $60.00 to $86.00. They now have a "buy" rating on the stock.
Ratings data for CYTK provided by MarketBeat
Stopped prediction by Truist_Financial_Co_ for Cytokinetics Inc.
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€68.00
08.04.24
08.04.24
€79.21
08.04.25
08.04.25
-9.56%
26.04.24
26.04.24
